Converting a c-type to a b-type Cytochrome:  Met61 to His61 Mutant of Pseudomonas Cytochrome c-551 von Miller, Gregory T, Zhang, Balli, Hardman, John K, Timkovich, Russell

Volltext

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 von Peters, S., Scherpereel, A., Cornelissen, R., Oulkhouir, Y., Greillier, L., Kaplan, M.A., Talbot, T., Monnet, I., Hiret, S., Baas, P., Nowak, A.K., Fujimoto, N., Tsao, A.S., Mansfield, A.S., Popat, S., Zhang, X., Hu, N., Balli, D., Spires, T., Zalcman, G.

Volltext

Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation von Balli, D, Ren, X, Chou, F-S, Cross, E, Zhang, Y, Kalinichenko, V V, Kalin, T V

Volltext

Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition von Balli, David, Ustiyan, Vladimir, Zhang, Yufang, Wang, I-Ching, Masino, Alex J, Ren, Xiaomeng, Whitsett, Jeffrey A, Kalinichenko, Vladimir V, Kalin, Tanya V

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

The Large Hadron–Electron Collider at the HL-LHC von Aksakal, H, Alekhin, S, Allport, P P, Aperio Bella, L, Apyan, A, Arduini, G, Backovic, S, Behera, S, Blümlein, J, Bordry, F, Boroun, G R, Bottura, L, Calıskan, A, Camarda, S, Cassou, K, Cetinkaya, V, Chetvertkova, V, Cole, B, Cooper-Sarkar, A, Cornell, A S, Currie, J, Dainton, J, Das, S P, de Blas, J, Douglas, D, Dupraz, K, Dutta, S, Efremov, A V, Godbole, R M, Gonzalez-Sprinberg, G A, Goyal, A, Grames, J, Grassellino, A, Gunaydin, Y O, Harland-Lang, L, Hessler, J, Holzer, B, Hu, N, Islam, R, Iwamoto, S, Jones, T, Klein, M, Kocak, F, Kostka, P, Kulipanov, G, Kumar, M, Levitchev, E, Liu, M, Lobodzinska, E, Luo, X, Machado, M, Marhauser, F, Marzani, S, Meot, F, Mitra, M, Moretti, S, Morgan, T, Niehues, J, Osborne, J A, Pan, R, Paukkunen, H, Pellegrini, D, Perez-Segurana, G, Pire, B, Poelker, M, Polini, A, Rabbertz, K, Radescu, V, Rahaman, R, Rai, S K, Raicevic, N, Ratoff, P, Raut, D, Repond, J, Rimmer, R, Satyanarayan, N, Sinha, N, Smith, S, Strikman, M, Sultansoy, S, Sutton, M, Tanaka, M, Tang, Y, Tasci, A T, Ten-Kate, A T, Thonet, P, Trott, M, Tudora, A, Tywoniuk, K, Valloni, A, Wang, B, Wang, X, Wang, Z S, Xu, T, Yaguna, C E, Yamazaki, Y, Zhang, R, Zhang, Z, Zhu, S, Zurita, P

Volltext

On Randomized Linear Network Codes and Their Error Correction Capabilities von Balli, H., Xijin Yan, Zhen Zhang

Volltext

MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma von Maddipati, Ravikanth, Norgard, Robert J, Baslan, Timour, Rathi, Komal S, Zhang, Amy, Saeid, Asal, Higashihara, Taku, Wu, Feng, Kumar, Angad, Annamalai, Valli, Bhattacharya, Saurav, Raman, Pichai, Adkisson, Christian A, Pitarresi, Jason R, Wengyn, Maximilian D, Yamazoe, Taiji, Li, Jinyang, Balli, David, LaRiviere, Michael J, Ngo, Tuong-Vi C, Folkert, Ian W, Millstein, Ian D, Bermeo, Jonathan, Carpenter, Erica L, McAuliffe, John C, Oktay, Maja H, Brekken, Rolf A, Lowe, Scott W, Iacobuzio-Donahue, Christine A, Notta, Faiyaz, Stanger, Ben Z

Volltext

Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis von Cai, Yuqi, Balli, David, Ustiyan, Vladimir, Fulford, Logan, Hiller, Andrea, Misetic, Vinko, Zhang, Yufang, Paluch, Andrew M., Waltz, Susan E., Kasper, Susan, Kalin, Tanya V.

Volltext

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain M... von Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Cobo, Manuel, Bennouna, Jaafar, Schenker, Michael, Cheng, Ying, Juan-Vidal, Oscar, Mizutani, Hideaki, Lingua, Alejo, Reyes-Cosmelli, Felipe, Reinmuth, Niels, Menezes, Juliana, Jassem, Jacek, Protsenko, Svetlana, Richardet, Eduardo, Felip, Enriqueta, Feeney, Kynan, Zurawski, Bogdan, Alexandru, Aurelia, de la Mora Jimenez, Emmanuel, Dakhil, Shaker, Lu, Shun, Reck, Martin, John, Thomas, Hu, Nan, Zhang, Xiaoqing, Sylvester, Judi, Eccles, Laura J., Grootendorst, Diederik J., Balli, David, Neely, Jaclyn, Carbone, David P.

Volltext

Endothelial Cell-Specific Deletion of Transcription Factor FoxM1 Increases Urethane-Induced Lung Carcinogenesis von BALLI, David, YUFANG ZHANG, SNYDER, Jonathan, KALINICHENKO, Vladimir V, KALIN, Tanya V

Volltext

788O Association of pre-treatment ctDNA with disease recurrence and clinical and translational factors in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy... von Long, G.V., Desai, K., Tang, T., Weber, J.S., Dolfi, S., Ritchings, C., Huang, S-P., Bolisetty, M., Sausen, M., Del Vecchio, M., Larkin, J., Baden, J., Balli, D., Chang, H., Loffredo, J., Zhang, N., Wind-Rotolo, M., Tenney, D.

Volltext

First-line (1L) nivolumab (N) + ipilimumab (I) + chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes b... von Carbone, David Paul, Ciuleanu, Tudor-Eliade, Schenker, Michael, Cobo-Dols, Manuel, Bordenave, Stephanie, Juan-Vidal, Oscar, Janoski De Menezes, Juliana, Reinmuth, Niels, Richardet, Eduardo, Cheng, Ying, Mizutani, Hideaki, Paz-Ares, Luis G., Lu, Shun, John, Tom, Zhang, Xiaoqing, Hu, Nan, Balli, David, Baxi, Vipul, Neely, Jaclyn, Reck, Martin

Volltext

PP01.118 First-line Nivolumab (N) + Ipilimumab (I) + Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update von Badin, Firas, Carbone, David P., Ciuleanu, Tudor-Eliade, Schenker, Michael, Cobo-Dols, Manuel, Bordenave, Stephanie, Juan-Vidal, Oscar, Menezes, Juliana, Reinmuth, Niels, Richardet, Eduardo, Cheng, Ying, Mizutani, Hideaki, Paz-Ares, Luis G., Lu, Shun, John, Thomas, Zhang, Xiaoqing, Hu, Nan, Balli, David, Baxi, Vipul, Neely, Jaclyn, Reck, Martin

Volltext

LBA65 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (MPM): 3-year update from CheckMa... von Peters, S., Scherpereel, A., Cornelissen, R., Oulkhouir, Y., Greillier, L., Kaplan, M.A., Talbot, T., Monnet, I., Hiret, S., Baas, P., Nowak, A.K., Fujimoto, N., Tsao, A.S., Mansfield, A.S., Popat, S., Zhang, X., Hu, N., Balli, D., Sanzari, J., Zalcman, G.

Volltext

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial von Borghaei, H, O'Byrne, K J, Paz-Ares, L, Ciuleanu, T-E, Yu, X, Pluzanski, A, Nagrial, A, Havel, L, Kowalyszyn, R D, Valette, C A, Brahmer, J R, Reck, M, Ramalingam, S S, Zhang, L, Ntambwe, I, Rabindran, S K, Nathan, F E, Balli, D, Wu, Y-L

Volltext

Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis von Wang, I-Ching, Meliton, Lucille, Ren, Xiaomeng, Zhang, Yufang, Balli, David, Snyder, Jonathan, Whitsett, Jeffrey A, Kalinichenko, Vladimir V, Kalin, Tanya V

Volltext

Abstract PO-053: MYC Influences metastatic heterogeneity in pancreatic cancer von Maddipati, Ravikanth, Norgard, Robert J., Baslan, Timour, Rathi, Komal S., Zhang, Amy, Raman, Pichai, Wengyn, Max D., Yamazoe, Taiji, Li, Jinyang, Balli, David, LaRiviere, Michael J., Folkert, Ian W., Millstein, Ian D., Bermeo, Jonathan, Carpenter, Erica L., Lowe, Scott, Iacobuzio-Donahue, Christine, Notta, Faiyaz, Stanger, Ben Z.

Volltext

Abstract PO-071: MYC influences metastatic heterogeneity in pancreatic cancer von Maddipati, Ravikanth, Norgard, Robert J., Baslan, Timour, Rathi, Komal S., Zhang, Amy, Raman, Pichai, Wengyn, Max D., Yamazoe, Taiji, Li, Jinyang, Balli, David, LaRiviere, Michael, Folkert, Ian W., Millstein, Ian D., Bermeo, Jonathan, Carpenter, Erica L., Lowe, Scott, Iacobuzio-Donahue, Christine, Notta, Faiyaz, Stanger, Ben Z.

Volltext

EN1-3. 1L nivolumab + ipilimumab + chemotherapy (C) vs C alone in metastatic NSCLC : CheckMate 9LA 4 y data von Satoshi Ikeda, David P.Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, Manuel Cobo-Dols, Stephanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Niels Reinmuth, Eduardo Richardet, Ying Cheng, Hideaki Mizutani, Luis G.Paz-Ares, Shun Lu, Thomas John, Xiaoqing Zhang, Nan Hu, David Balli, Vipul Baxi, Jaclyn Neely, Martin Reck

Volltext